Insider · CIK 0001539215

Bhatt Padmanabh P.

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001539215

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+2,500 sh	—	—	19,795
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−2,500 sh	—	—	0
2026-08-12	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. VP of IP, CSO	FTax Payment	−1,158 sh	$46.57	−$53.9K	18,637
2026-07-29	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Sr. VP of IP, CSO	AAward	+2,500 sh	—	—	2,500
2026-03-18	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of IP, CSO	SSale	−6,838 sh	$49.55	−$339K	17,456
2026-03-18	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+7,250 sh	$39.40	+$286K	24,294
2026-03-18	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of IP, CSO	SSale	−412 sh	$50.48	−$20.8K	17,044
2026-03-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−7,250 sh	—	—	0
2026-03-17	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of IP, CSO	SSale	−22.3K sh	$50.73	−$1.13M	17,044
2026-03-17	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−22.8K sh	—	—	7,250
2026-03-17	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+22.8K sh	$39.40	+$896K	39,794
2026-03-17	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+12.3K sh	$36.75	+$450K	52,044
2026-03-17	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−15K sh	—	—	5,000
2026-03-17	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−12.3K sh	—	—	0
2026-03-17	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+15K sh	$38.60	+$579K	67,044
2026-03-17	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of IP, CSO	SSale	−27.7K sh	$49.95	−$1.38M	39,334
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+4,250 sh	$29.61	+$126K	44,044
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+22.8K sh	$36.75	+$836K	39,794
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−18K sh	—	—	0
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−5,000 sh	—	—	15,000
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−22.8K sh	—	—	12,250
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of IP, CSO	SSale	−34.1K sh	$50.18	−$1.71M	32,930
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+18K sh	$32.20	+$580K	62,044
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of IP, CSO	SSale	−15.9K sh	$50.49	−$802K	17,044
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−4,250 sh	—	—	0
2026-03-16	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+5,000 sh	$27.94	+$140K	67,044
2026-02-25	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Sr. VP of IP, CSO	DDisposition to Issuer	−1,250 sh	—	—	1,250
2026-02-25	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. VP of IP, CSO	FTax Payment	−650 sh	$50.69	−$32.9K	17,044
2026-02-25	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Sr. VP of IP, CSO	AAward	+1,250 sh	—	—	17,694
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Sr. VP of IP, CSO	AAward	+1,125 sh	—	—	16,025
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Sr. VP of IP, CSO	DDisposition to Issuer	−750 sh	—	—	0
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Sr. VP of IP, CSO	AAward	+750 sh	—	—	16,194
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. VP of IP, CSO	FTax Payment	−581 sh	$51.35	−$29.8K	15,444
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Sr. VP of IP, CSO	DDisposition to Issuer	−1,250 sh	—	—	2,500
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Sr. VP of IP, CSO	AAward	+1,250 sh	—	—	17,090
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. VP of IP, CSO	FTax Payment	−354 sh	$50.86	−$18K	15,840
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Sr. VP of IP, CSO	DDisposition to Issuer	−1,125 sh	—	—	3,375
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. VP of IP, CSO	FTax Payment	−646 sh	$50.86	−$32.9K	16,444
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. VP of IP, CSO	AAward	+13.5K sh	—	—	13,500
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Sr. VP of IP, CSO	AAward	+3,000 sh	—	—	3,000
2025-12-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−1,500 sh	—	—	0
2025-12-18	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. VP of IP, CSO	SSale	−710 sh	$44.44	−$31.6K	14,508
2025-12-18	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+1,500 sh	—	—	15,218
2025-11-13	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Sr. VP of IP, CSO	AAward	+1,500 sh	—	—	1,500
2025-08-25	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	−1,250 sh	—	—	0
2025-08-25	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. VP of IP, CSO	FTax Payment	−581 sh	$41.46	−$24.1K	13,718
2025-08-25	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. VP of IP, CSO	MExercise/Conversion	+1,250 sh	—	—	14,299
2025-08-07	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Sr. VP of IP, CSO	AAward	+1,250 sh	—	—	1,250
2025-03-05	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. VP of IP, CSO	FTax Payment	−335 sh	$33.05	−$11.1K	13,854
2025-03-05	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. VP of IP, CSO	FTax Payment	−575 sh	$33.05	−$19K	12,704

Recent filings

Accepted (ET)
Aug 144
Bhatt Padmanabh P.0001539215-26-000012
SEC(opens sec.gov)
Jul 314
Bhatt Padmanabh P.0001539215-26-000010
SEC(opens sec.gov)
Mar 184
Bhatt Padmanabh P.0001539215-26-000008
SEC(opens sec.gov)

Companies

SUPERNUS PHARMACEUTICALS, INC.Sr. VP of IP, CSOSUPN

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850